Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence

European Psychiatry

Volumn 19, Issue 7, 2004, Pages 415-422

  Lambert, M ^a   Conus, P ^b   Eide, P ^c   Mass, R ^a   Karow, A ^a   Moritz, S ^a   Golks, D ^a   Naber, D ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^c THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

Adherence; Attitude; Schizophrenia; Side effects; Typical antipsychotics

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HOSPITAL; PATIENT ATTITUDE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHIZOPHRENIA; SEDATION; SEXUAL DYSFUNCTION;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; BASAL GANGLIA DISEASES; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; PATIENT COMPLIANCE; SCHIZOPHRENIA; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 7044260514     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.06.031     Document Type: Article

References (44)

1. Affleck J.W., Burns J., and Forrest A.D. Long-term follow-up of schizophrenic patients in Edinburgh Acta Psychiatr Scand 53 3 1976 227 237
2. Allison D.B., Mackell J.A., and McDonnell D.D. The impact of weight gain on quality of life among persons with schizophrenia Psychiatr Serv 54 4 2003 565 567
3. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., and Gorman J.M. Assessment of insight in psychosis Am J Psychiatry 150 6 1993 873 879
4. Angermeyer M.C., and Matschinger H. Antipsychotics and quality of life. A patient survey Psychiatry Prax 27 2 2000 64 68
5. Awad A.G., Voruganti L.N., Heslegrave R.J., and Hogan T.P. Assessment of the patient's subjective experience in acute antipsychotic treatment: implications for compliance and outcome Int Clin Psychopharmacol 11 Suppl 2 1996 55 59
6. Berardi D., Giannelli A., and Barnes T.R. Clinical correlates of akathisia in acute psychiatric inpatients Int Clin Psychopharmacol 15 4 2000 215 219
7. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia Psychol Med 22 3 1992 787 797
8. Cabeza I.G., Amador M.S., Lopez C.A., and Gonzalez de Chavez M. Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors Schizophr Res 41 2 2000 349 355
9. Collins E.J., Hogan T.P., and Desai H. Measurement of therapeutic response in schizophrenia: a critical survey Schizophr Res 51 1991 249 253
10. Corrigan P.W., Liberman R.P., and Engel J.D. From noncompliance to collaboration in the treatment of schizophrenia Hosp Community Psychiatry 41 11 1990 1203 1211
11. Cuffel B.J., Alford J., Fischer E.P., and Owen R.R. Awareness of illness in schizophrenia and outpatient treatment adherence J Nerv Ment Dis 184 11 1996 653 659
12. David A., Buchanan A., Reed A., and Almeida O. The assessment of insight in psychosis Br J Psychiatry 161 1992 599 602
13. Davis J.M., Kane J.M., Marder S.R., Brauzer B., Gierl B., Schooler N., Casey D.E., and Hassan M. Dose response of prophylactic antipsychotics J Clin Psychiatry 54 Suppl 1993 24 30
14. De Haan L., Peters B., Dingemans P., Wouters L., and Linszen D. Attitudes of patients toward the first psychotic episode and the start of treatment Schizophr Bull 28 3 2002 431 442
15. Dixon L., Weiden P., and Torres M. Assertive community treatment and medication compliance in the homeless mentally ill Am J Psychiatry 154 1997 1302 1304
16. Donohoe G., Owens N., O'Donnell C., Burke T., Moore L., Tobin A., and O'Callaghan E. Predictors of compliance with antipsychotic medication among inpatients with schizophrenia: a discriminant function analysis Eur Psychiatry 16 5 2001 293 298
17. Fenton W.S., Blyler C.R., and Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings Schizophr Bull 23 4 1997 637 651
18. Fleischhacker W.W., Oehl M.A., and Hummer M. Factors influencing compliance in schizophrenia patients J Clin Psychiatry 64 Suppl 16 2003 10 13
19. Gervin M., Browne J., Garavan M., Roe C., Larkin C., and Callaghan O. Dysphoric subjective response to antipsychotics in schizophrenia: relationship to extrapyramidal side-effects and symptomatology Eur Psychiatry 14 1999 405 409
20. Hellewell J.S.E., Kalali A.H., and Langham S.J. Patient satisfaction and acceptability of long-term treatment with quetiapine Int J Psychiatry Clin Prac 3 1999 105 113
21. Hellewell J.S. Patients' subjective experiences of antipsychotics: clinical relevance CNS Drugs 16 7 2002 457 471
22. Hofer A., Kemmler G., Eder U., Honeder M., Hummer M., and Fleischhacker W.W. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia J Clin Psychiatry 63 1 2002 49 53
23. Holzinger A., Loffler W., Muller P., Priebe S., and Angermeyer M.C. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia J Nerv Ment Dis 190 9 2002 597 603
24. Jarema M., Murawiec S., Szafranski T., Szaniawska A., and Konieczynska Z. Subjective and objective evaluation of treating schizophrenia with classic or atypical drugs Psychiatr Pol 35 1 2001 5 19
25. Jeste S.D., Patterson T.L., Palmer B.W., Dolder C.R., Goldman S., and Jeste D.V. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia Schizophr Res 63 1-2 2003 49 58
26. Kampman O., Lehtinen K., Lassila V., Leinonen E., Poutanen O., and Koivisto A. Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire Schizophr Res 45 3 2000 223 234
27. Kampman O., Laippala P., Vaananen J., Koivisto E., Kiviniemi P., Kilkku N., and Lehtinen K. Indicators of medication compliance in first-episode psychosis Psychiatry Res 110 1 2002 39 48
28. Kemp R., and David A. Psychological predictors of insight and compliance in psychotic patients Br J Psychiatry 169 4 1996 444 450
29. Kemp R., Hayward P., Applewhaite G., Everitt B., and David A. Compliance therapy in psychotic patients: randomised controlled trial BMJ 10 7027 1996 345 349 312
30. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., and Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature J Clin Psychiatry 63 10 2002 892 909
31. Larsen E.B., and Gerlach J. Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot antipsychotics Acta Psychiatr Scand 93 5 1996 381 388
32. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., and Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients Acta Psychiatr Scand 334 Suppl 1987 1 100
33. Loffler W., Kilian R., Toumi M., and Angermeyer M.C. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment Pharmacopsychiatry 36 3 2003 105 112
34. Naber D., Moritz S., Lambert M., Pajonk F.G., Holzbach R., Mass R., Andresen B., and Rajonk F. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs Schizophr Res 50 1-2 2001 79 88
35. Overall J.E., and Gorham D.R. The brief psychiatric rating scale Psychological Reports 10 1986 799
36. Ritsner M., Ponizovsky A., Endicott J., Nechamkin Y., Rauchverger B., Silver H., and Modai I. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study Eur Neuropsychopharmacol 12 1 2002 31 38
37. Sajatovic M., Rosch D.S., Sivec H.J., Sultana D., Smith D.A., Alamir S., Buckley P., and Bingham C.R. Insight into illness and attitudes toward medications among inpatients with schizophrenia Psychiatr Serv 53 10 2002 1319 1321
38. Smith C.M., Barzman D., and Pristach C.A. Effect of patient and family insight on compliance of schizophrenic patients J Clin Pharmacol 37 2 1997 147 154
39. Van Putten T. Why do schizophrenic patients refuse to take their drugs? Arch Gen Psychiatry 31 1974 67 72
40. Van Putten T., Crumpton E., and Yale C. Drug refusal in schizophrenia and wish to be crazy Arch Gen Psychiatry 33 1976 1443 1446
41. Voruganti L., Cortese L., Oyewumi L., Cernovsky Z., Zirul S., and Awad A. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life Schizophr Res 43 2-3 2000 135 145
42. WHO SCAN-Schedules for clinical assessment in neuropsychiatry 1992 Genf: World Health Organization, Division of Mental Health
43. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics J Clin Psychiatry 64 2003 663 667
44. Zygmunt A., Olfson M., Boyer C.A., and Mechanic D. Interventions to improve medication adherence in schizophrenia Am J Psychiatry 159 10 2002 1653 1664